Supply Chain · Operations & Supply Chain
Should you build or buy Pharma & Food Serialization / Track-and-Trace Platform?
Pharma and food serialization / track-and-trace platforms assign unique identifiers to individual product units and manage those identifiers across the full supply chain — from manufacturing line to retail shelf — to meet regulatory requirements like DSCSA 2023 for pharmaceuticals and FSMA for food. They handle the connectivity to FDA interchange systems, trading partner verification, and the data architecture required for lot-level and unit-level traceability.
The build-vs-buy decision for Pharma & Food Serialization / Track-and-Trace Platform turns on how much of the value is locked in pre-certified connections to regulatory authority systems and trading partner networks that vendors maintain as a core service, versus the degree to which your packaging line architecture and distribution model require custom serialization logic; the regulatory connectivity requirements typically dominate the calculus.
Build it, buy it, or bridge?
When building makes sense
Building serialization infrastructure is defensible for a very large manufacturer with multiple packaging lines, a complex L3/L4/L5 architecture that differs from vendor templates, and the engineering resources to navigate regulatory certification independently. The serialization logic itself — assigning and managing serial numbers, handling aggregation and disaggregation events — is buildable. The hard parts are the external connections: DSCSA requires verified connectivity to the FDA DSCSA interchange and trading partner acknowledgment systems that must pass third-party certification. That certification process is not a coding challenge; it is a regulatory compliance process. Companies that have attempted to build this from scratch have found that the compliance maintenance burden — updating to new DSCSA transaction data standards, handling trading partner format variations — compounds over time and requires a dedicated compliance engineering function that most organizations did not anticipate.
When buying makes sense
Buying a serialization platform makes sense for most pharma manufacturers and distributors because the regulatory connectivity is the hard problem, and vendors have already solved it. TraceLink, SAP ATTP, and Systech maintain certified connections to the FDA DSCSA interchange and the EMVO hub for EU FMD — connections that require ongoing certification as standards evolve. The trading partner network effects are also significant: a platform with broad pharmacy and distributor connectivity means your serialized data reaches counterparties without bilateral technical negotiations. For food companies under FSMA Section 204, the lot-level traceability requirements have similar structured data and reporting obligations that platforms have pre-built. If you are a mid-size manufacturer, the ROI math on buying vs. building the regulatory infrastructure alone typically closes the case.
The desk read
DSCSA 2023 and EU FMD don't just require serialization data, they require connectivity to regulatory authority systems: the FDA DSCSA interchange, the EMVO hub for EU FMD, and certified messaging infrastructure that pharmaceutical companies cannot build themselves. TraceLink and SAP ATTP have maintained that regulatory connectivity and the certification documentation that trading partners and regulators require for years. OPTEL Group and Antares Vision serve the manufacturing line integration layer where L3/L4/L5 architecture implementation is the primary challenge.
The compliance consequence of serialization failure is operational stoppage, not a fine. Inability to verify serialized identifiers means inability to sell product in regulated markets. That's the architectural fact that shapes everything else in this category. The AI shift is modest here: AI-based label verification and aggregation error detection are incremental improvements on top of systems where the regulatory connectivity requirement doesn't change. The buy case doesn't require detailed analysis because self-build is not viable given the regulatory authority connectivity requirements. The question is which vendor's implementation fits your packaging line architecture and trading partner network.
Frequently asked
What is a Pharma & Food Serialization / Track-and-Trace Platform?
Pharma and food serialization / track-and-trace platforms assign unique identifiers to individual product units and manage those identifiers across the full supply chain — from manufacturing line to retail shelf — to meet regulatory requirements like DSCSA 2023 for pharmaceuticals and FSMA for food. They handle the connectivity to FDA interchange systems, trading partner verification, and the data architecture required for lot-level and unit-level traceability.
When does building Pharma & Food Serialization / Track-and-Trace Platform make sense?
Building is defensible for very large manufacturers with complex, non-standard packaging line architectures and the engineering resources to pursue regulatory certification independently. The serialization logic is buildable; the regulatory connectivity and certification maintenance are the parts that typically push large programs back toward commercial platforms.
When does buying Pharma & Food Serialization / Track-and-Trace Platform make sense?
Buying makes sense for most pharma manufacturers and distributors because vendors carry pre-certified connections to the FDA DSCSA interchange and EMVO hub — regulatory connections that require ongoing maintenance as standards evolve and that most companies cannot maintain cost-effectively in-house.
What are the main Pharma & Food Serialization / Track-and-Trace Platform vendors?
Representative vendors include TraceLink (Opus platform), SAP ATTP (Advanced Track and Trace), Systech, OPTEL Group (Optchain). B4 Pro scores the full set.
What is the difference between serialization at L3 versus L4 versus L5?
L3 (line level) handles serialization and aggregation on the packaging line. L4 (site level) manages lot and batch records across a facility. L5 (enterprise/network level) connects to trading partners, regulatory authorities, and third-party logistics providers. Most regulatory mandates care most about L5 — the connectivity and data exchange layer — which is where vendor differentiation is strongest.